Jennifer Bragg Email & Phone Number

New York, Us

New York, Ny, Us

Notable representations include, among others:Litigation/Investigations - Purdue Pharma L.P. in connection with emerging developments relating to the marketing of opioid medications, including its successful resolution of Department of Justice (DOJ) civil and criminal investigations concerning the sale and marketing of opioid products;- Pfizer Inc. in securing an order to vacate an Amended Consent Decree (Amended Decree) entered into with the FDA and DOJ. In granting the order, the court found that Pfizer had satisfied the conditions for relief from the Amended Decree and that it should be vacated;- Miraca Holdings, Inc. in securing the dismissal of claims brought by a qui tam relator under the federal False Claims Act and the California and North Carolina state analogues;- CareFusion Corporation in securing the settlement and resolution of a DOJ claim alleging that between 2007 and 2014 CareFusion sold medical devices that were not approved by the FDA;Regulation- a pharmaceutical company in connection with strategic regulatory and litigation issues associated with a competing product’s orphan exclusivity;- a global pharmaceutical and device company in connection with sophisticated digital health issues;- a biopharmaceutical company in connection with a request to the FDA to change the determination to permanently bar a former FDA employee subsequently employed by the company from participating in matters involving the company’s non-disclosure agreement;Mergers and Acquisitions- Cardinal Health, Inc. in its $6.1 billion acquisition of the patient care, deep vein thrombosis and nutritional insufficiency businesses of Medtronic plc;- Miraca Holdings, Inc. in the acquisition of its subsidiary Miraca Life Sciences, Inc. by Avista Capital Holdings, L.P.; and- Stryker Corporation in its: $3 billion acquisition of Vocera Communications, Inc.; acquisition of a 51% stake in Vexim SA; and $662 million acquisition of Entellus Medical, Inc.

Atlanta, Ga, Us

Silver Spring, Md, Us

From 1998 to 2003, as the FDA’s associate chief counsel, I advised its Office of Criminal Investigations. During that time, I tried to verdict four criminal jury trials involving violations of the Federal Food, Drug and Cosmetic Act (FDCA) and other federal statutes. My matters involved compounding pharmacies, unapproved pharmaceuticals, controlled substances, misbranded devices and food-related good manufacturing practices. I also was designated by the DOJ to serve as a special assistant U.S. attorney in various districts throughout the country regarding ongoing criminal investigations under the FDCA. Additionally, I served as the FDA Office of Chief Counsel’s primary liaison with the Office of Criminal Investigations relating to policy issues.

Doctor Of Law - Jd

Bachelor Of Arts - Ba, Journalism